Last updated on April 2019

A Study of Parsaclisib in Primary Sj gren's Syndrome

Brief description of study

The purpose of this study is to assess the impact of parsaclisib on the signs and symptoms of Sjgren's syndrome (SS).

Clinical Study Identifier: NCT03627065

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.